Form 10-Q · Quarterly report
International Flavors & Fragrances 10-Q, filed Nov 3, 2026
- Filed
- CIK
- 0000051253
- Accession no.
- 0000051253-26-000041
Summary
International Flavors & Fragrances reported third-quarter 2026 net sales of $1.942 billion, up 4% from a year earlier on 5% volume growth across its Taste, Health & Biosciences and Scent segments, and a net loss attributable to shareholders of $55 million that included a $236 million loss on assets classified as held for sale. The company said its agreement to divest its Food Ingredients disposal group, announced May 29, 2026, is expected to close in the second quarter of 2027 subject to customary closing conditions and regulatory approvals.
Key points
- Third-quarter 2026 net loss from continuing operations was $127 million, compared with income of $99 million a year earlier.
- Gross profit rose 3% to $825 million, while operating profit fell 16% to $160 million.
- A $23 million goodwill impairment was recorded for the Botanicals & Food Enhancements disposal group.
- Selling and administrative expenses rose 11% to $387 million, driven partly by $28 million of additional regulatory costs.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION OVERVIEW Company Background We are organized into three reportable operating segments: Taste, Health & Biosciences, and Scent. Our Taste segment consists of the development and production of a range of flavor compounds and natural taste solutions that are ultimately used by our customers in a diverse variety of products, including savory products (soups, sauces, meat, fish, poultry, snacks, etc.), beverages (juice drinks, carbonated or flavored beverages, spirits, etc.), sweets (bakery products, candy, cereal, chewing gum, etc.), and dairy products (yogurt, ice cream, cheese, etc.). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.